Catalogue - Canadian Urban Data Catalogue (CUDC)

Advanced Filter

Organizations

Groups

There are no Groups that match this search

Formats

Show More Formats

Licenses

Domain / Topic

Format (CSV, XLS, TXT, PDF, etc)

There are no Format (CSV, XLS, TXT, PDF, etc) that match this search

Dataset Size

There are no Dataset Size that match this search

Metadata Identifier

There are no Metadata Identifier that match this search

Published Date

Show More Published Date

Time Period Data Span (start date)

There are no Time Period Data Span (start date) that match this search

Time Period Data Span (end date)

There are no Time Period Data Span (end date) that match this search

GeoSpatial Area Data Span

There are no GeoSpatial Area Data Span that match this search

Access category

There are no Access category that match this search

Limits on use

There are no Limits on use that match this search

Location

There are no Location that match this search

Data Service

There are no Data Service that match this search

Owner

Contact Point

There are no Contact Point that match this search

Contact Point Email

There are no Contact Point Email that match this search

Publisher

There are no Publisher that match this search

Publisher Email

Show More Publisher Email

Accessed At

There are no Accessed At that match this search

Identifier

There are no Identifier that match this search

Language

There are no Language that match this search

Link to dataset description

There are no Link to dataset description that match this search

Persistent Identifier

There are no Persistent Identifier that match this search

Globally Unique Identifier

There are no Globally Unique Identifier that match this search

Contains data about individuals

There are no Contains data about individuals that match this search

Contains data about identifiable individuals

There are no Contains data about identifiable individuals that match this search

Contains Indigenous Data

There are no Contains Indigenous Data that match this search

Version notes

There are no Version notes that match this search

Is version of another dataset

There are no Is version of another dataset that match this search

Other versions

There are no Other versions that match this search

Provenance Text

There are no Provenance Text that match this search

Provenance URL

There are no Provenance URL that match this search

Temporal resolution

There are no Temporal resolution that match this search

GeoSpatial resolution in meters

There are no GeoSpatial resolution in meters that match this search

GeoSpatial resolution (in regions)

There are no GeoSpatial resolution (in regions) that match this search

Indigenous Community Permission

There are no Indigenous Community Permission that match this search

Community Permission

There are no Community Permission that match this search

The Indigenous communities the dataset is about

There are no The Indigenous communities the dataset is about that match this search

Number of data rows

There are no Number of data rows that match this search

Number of data columns

There are no Number of data columns that match this search

Number of data cells

There are no Number of data cells that match this search

Number of data relations

There are no Number of data relations that match this search

Number of entities

There are no Number of entities that match this search

Number of data properties

There are no Number of data properties that match this search

Data quality

There are no Data quality that match this search

Metric for data quality

There are no Metric for data quality that match this search

Catalogue Entry: Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)

The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL)...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)

The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use:...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27)

The purpose of this Notice of Amendment is to notify about the additions of: - Strain Russian BCG-I to the "including" column of the |Bacillus Calmette-Guérin (BCG)" entry on...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Vitamin D

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Triamcinolone acetonide

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)

The purpose of this Notice of Amendment is to notify about the addition of sotrovimab to the Prescription Drug List (PDL) for human and veterinary use.
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Polymyxin B

The purpose of this Notice of Amendment is to notify that Health Canada will switch certain uses of Polymyxin B to prescription status for veterinary use by adding it to the...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Nicotine Qualifier Clarification

The purpose of this Notice of Amendment is to notify that Health Canada is clarifying the nicotine qualifier entry on the PDL. Only the qualifier for human use is being revised.
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Naproxen

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for naproxen on the Prescription Drug List (PDL). Only the Human part of the PDL...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Naloxone

The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL).
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Minoxidil

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for minoxidil on the Prescription Drug List (PDL). Only the Human part of the PDL...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Hyoscine butylbromide

The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Hydrocortisone

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for hydrocortisone on the Prescription Drug...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Human and Veterinary Antimicrobials

The purpose of this Notice of Amendment is to notify that Health Canada has amended 14 antimicrobial active ingredients or their salts or derivatives from non-prescription to...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Fluticasone propionate

The purpose of this Notice of Amendment is to notify that Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt certain...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Omeprazole

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for omeprazole on the Prescription Drug List (PDL). Only the Human part of the...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Esomeprazole

The purpose of this Notice of Amendment is to notify that Health Canada will switch certain uses of Esomeprazole to nonprescription status for human use by modifying the Human...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Diclofenac

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for diclofenac on the Prescription Drug List (PDL). Only the Human part of the...
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19)

The purpose of this Notice of Amendment is to notify about the addition of casirivimab and imdevimab to the Prescription Drug List (PDL) for human and veterinary use.
- HTML
Catalogue Entry: Notice: Prescription Drug List (PDL): Avilamycin

The purpose of this Notice of Amendment is to notify the addition of avilamycin to both the Human and Veterinary Prescription Drug List (PDL).
- HTML

You can also access this registry using the API (see API Docs).

2,942 catalogue entries found